Goldman Sachs Predicts FDA To Approve Coronavirus Vaccine This Year


Goldman Sachs expects the Food and Drug Administration to approve at least one vaccine against the coronavirus this year. This would allow “large parts” of the American population to be vaccinated by July of next year, according to the investment bank.“Although very uncertain, our basic expectation is that a large number of vaccines will eventually be approved with at least one FDA approval this year,” Daan Struyven, senior economist at Goldman, said in a report on Monday.

Drugmakers have 26 vaccines in clinical trials, he noted. Of the applicants, a dozen have reached phase II trials and six that are in phase III undergoing large-scale efficacy and safety testing. For Europeans, US regulatory approval of an initial vaccine would allow them to be vaccinated by October.


Please enter your comment!
Please enter your name here